Starfish Neuroscience develops miniaturized, wireless, battery-free brain–computer interface (BCI) chips designed to enable simultaneous neural recording and stimulation across multiple brain regions. The company’s technology focuses on creating compact, implantable devices capable of high-resolution, bidirectional neural interfacing. Its approach emphasizes scalability, chronic use, and integration into future therapeutic applications. Starfish Neuroscience positions its technology within regulated clinical research and experimental neurotechnology contexts.

The technology uses low-power, wireless electronics to record neural activity while delivering targeted stimulation in real time. Battery-free operation is enabled through external power transfer or energy-harvesting methods, reducing implant size and complexity. The system supports multi-site cortical and subcortical interfacing, enabling coordinated neuromodulation and monitoring. This architecture emphasizes high fidelity, adaptability, and potential for integration with closed-loop therapeutic protocols.

Starfish Neuroscience targets applications in future neurological therapies, including neurorehabilitation and neuromodulation for complex disorders. The platform is intended for use in investigational and clinical research rather than immediate consumer or home deployment. Its positioning reflects broader efforts to advance scalable, wireless BCIs that combine recording and stimulation for precise, multi-region neural control.